表紙
市場調查報告書

臨床試驗用包裝·標籤市場預測 - 一次包裝,二次包裝:2020年∼2030年

Clinical Trial Packaging and Labelling Market Forecast 2020-2030: Revenue Prospects by Type - Primary Packaging, Secondary Packaging, End Users, Profiles of Leading Companies, Regional and Leading National Market Analysis

出版商 Visiongain Ltd 商品編碼 934305
出版日期 內容資訊 英文 171 Pages
商品交期: 最快1-2個工作天內
價格
臨床試驗用包裝·標籤市場預測 - 一次包裝,二次包裝:2020年∼2030年 Clinical Trial Packaging and Labelling Market Forecast 2020-2030: Revenue Prospects by Type - Primary Packaging, Secondary Packaging, End Users, Profiles of Leading Companies, Regional and Leading National Market Analysis
出版日期: 2020年03月24日內容資訊: 英文 171 Pages
簡介

本報告提供全球臨床試驗用包裝·標籤市場相關調查分析,提供市場概要,市場動態,市場預測,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

第2章 臨床試驗用包裝·標籤的簡介

  • 包裝的種類
  • 包裝材料費的種類

第3章 定性分析:臨床試驗用包裝·標籤市場

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場課題
  • SWOT分析
  • PEST分析
  • 波特的五力分析

第4章 全球臨床試驗用包裝·標籤市場:各類型

  • 簡介
    • 一次包裝
    • 二次包裝

第5章 全球臨床試驗用包裝·標籤市場:各終端用戶

  • 簡介
    • 製藥公司
    • 研究實驗室
    • CRO

第6章 全球臨床試驗用包裝·標籤市場

第7章 北美的臨床試驗用包裝·標籤市場

  • 美國
  • 加拿大

第8章 歐洲的臨床試驗用包裝·標籤市場

  • 德國
  • 法國
  • 英國(UK)
  • 義大利
  • 西班牙
  • 其他

第9章 亞太地區的臨床試驗用包裝·標籤市場

  • 中國
  • 日本
  • 印度
  • 澳洲
  • ASEAN
  • 其他

第10章 南美的臨床試驗用包裝·標籤市場

  • 巴西
  • 墨西哥
  • 其他

第11章 中東·非洲的臨床試驗用包裝·標籤市場

  • GCC
  • 南非
  • 其他

第12章 臨床試驗用包裝·標籤市場上主要企業

第13章 臨床試驗用包裝·標籤市場結論

第14章 詞彙表

目錄
Product Code: MAT0165

Clinical Trials Packaging and Labelling- our new study reveals trends, R&D progress, and predicted revenues

Where is the Clinical Trial Packaging and Labelling market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 171 pages report provides 96 tables, 50 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Clinical Trial Packaging and Labelling Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are following segments, each forecasted at a global and regional level.

Clinical Trial Packaging and Labelling Market by Type

Primary Packaging

  • Blisters
  • Bottles
  • Pouches
  • Tubes
  • Others

Secondary Packaging

  • Labelling for Parenteral and Injectable
  • Just in Time Labelling
  • Tyvek Blistering for Parenteral
  • Cartons
  • Others

Clinical Trial Packaging and Labelling Market by End Users

  • CRO's
  • Drug Manufacturing Companies
  • Research Labs

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:

North America

  • U.S.
  • Canada
  • Latin America:
  • Brazil
  • Mexico
  • Rest of Latin America

Europe (EU)

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific (APAC)

  • Japan
  • China
  • India
  • Australia
  • ASEAN
  • Rest of Asia-Pacific

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Clinical Trial Packaging and Labelling market, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

Overall world revenue for Clinical Trial Packaging and Labelling Market will surpass $900 million in 2020, our work calculates. We predict strong revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Clinical Trial Packaging and Labelling Market report helps you

In summary, our 181 pages report provides you with the following knowledge:

  • Revenue forecasts to 2030 for 5 regional and 17 key national markets- See forecasts for the Clinical Trial Packaging and Labelling market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, ASEAN countries, GCC Countries and South Africa.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 13 of the major companies involved in the Clinical Trial Packaging and Labelling market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Clinical Trial Packaging and Labelling market and leading companies. You will find data, trends and predictions.

Buy our report today Clinical Trial Packaging and Labelling Market Forecast 2020-2030: Revenue Prospects by Type (Primary Packaging (Blisters, Bottles, Pouches, Tubes, Others), Secondary Packaging (Labelling for Parenteral and Injectable, Just in Time Labelling, Tyvek Blistering for Parenteral, Cartons, Others)), End Users (Drug Manufacturing Companies, Research Labs and CROs), Profiles of Leading Companies and Regional and Leading National Market Analysis. Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Global Clinical Trial Packaging and Labelling Market Overview
  • 1.2 Overview of Findings
  • 1.3 Structure of the Report
  • 1.4 Global Clinical Trial Packaging and Labelling Market Segmentation
  • 1.5 Why You Should Read This Report
  • 1.6 How This Report Delivers
  • 1.7 Key Questions Answered by This Analytical Report
  • 1.8 Who is This Report For?
  • 1.9 Methodology
  • 1.10 Associated Visiongain Reports
  • 1.11 About Visiongain

2 Introduction to Clinical Trial Packaging and Labelling

  • 2.1 Types of Packages
    • 2.1.1 Syringes
    • 2.1.2 Bottles
    • 2.1.3 Blisters
    • 2.1.4 Cold forming
    • 2.1.5 Thermoforming
    • 2.1.6 Tubes
    • 2.1.7 Vials and Ampoules
    • 2.1.8 Bags
    • 2.1.9 Pouches
    • 2.1.10 Sachets
    • 2.1.11 Cups and closures
    • 2.1.12 Containers, Cartons, and Boxes
  • 2.2 Types of Packaging Materials
    • 2.2.1 Polyvinyl Chloride (PVC)
    • 2.2.2 High Density Polyethylene (HDPE)
    • 2.2.3 Low Density Polyethylene (LDPE)
    • 2.2.4 Polypropylene (PP)
    • 2.2.5 Glass
    • 2.2.6 Metal
    • 2.2.7 Paper
    • 2.2.8 Corrugated fibre

3 Qualitative Analysis: Clinical Trial Packaging and Labelling Market, 2020-2030

  • 3.1 Market Drivers
    • 3.1.1 Rising Number of Clinical Trials Coupled with Growing R&D Investments
    • 3.1.2 Growing innovations and technological advancements
    • 3.1.3 Changing Regulatory Scenario
  • 3.2 Market Restraints
    • 3.2.1 Lack of infrastructure & trained professionals
    • 3.2.2 Stringent regulatory scenario
    • 3.2.3 High waste
  • 3.3 Market Opportunities
    • 3.3.1 Tamper proof packaging
    • 3.3.2 Environmentally safe packaging
    • 3.3.3 Opportunities in biologics and biosimilars packaging materials
  • 3.4 Market Challenges
    • 3.4.1 High Industry Competition
    • 3.4.2 Low Volume Requirements of Clinical Trial Packaging Material
    • 3.4.3 Changing Regulatory Scenario
    • 3.4.4 Requirement Of Advanced Packing Material For Biologics
    • 3.4.5 Uncertainty due to BREXIT
  • 3.5 SWOT Analysis
    • 3.5.1 Strengths
    • 3.5.2 Weaknesses
    • 3.5.3 Opportunities
    • 3.5.4 Threats
  • 3.6 PEST Analysis
    • 3.6.1 Political
    • 3.6.2 Economical
    • 3.6.3 Social
    • 3.6.4 Technological
  • 3.7 Porter's Five Forces Analysis
    • 3.7.1 Bargaining power of suppliers
    • 3.7.2 Bargaining power of buyers
    • 3.7.3 Industry rivalry
    • 3.7.4 Threat of substitutes
    • 3.7.5 Entry barriers

4 Global Clinical Trial Packaging and Labelling Market by Type, 2020-2030

  • 4.1 Introduction
    • 4.1.1 Primary Packaging
    • 4.1.2 Secondary Packaging

5 Global Clinical Trial Packaging and Labelling Market by End Users, 2020-2030

  • 5.1 Introduction
    • 5.1.1 Drug Manufacturing Companies
    • 5.1.2 Research Labs
    • 5.1.3 CRO's

6 Global Clinical Trial Packaging and Labelling Market, 2020-2030

7 North America Clinical Trial Packaging and Labelling Market, 2020-2030

  • 7.1 U.S. Clinical Trial Packaging and Labelling Market, 2020-2030
  • 7.2 Canada Clinical Trial Packaging and Labelling Market, 2020-2030

8 Europe Clinical Trial Packaging and Labelling Market, 2020-2030

  • 8.1 Germany Clinical Trial Packaging and Labelling Market, 2020-2030
  • 8.2 France Clinical Trial Packaging and Labelling Market, 2020-2030
  • 8.3 United Kingdom (UK) Clinical Trial Packaging and Labelling Market, 2020-2030
  • 8.4 Italy Clinical Trial Packaging and Labelling Market, 2020-2030
  • 8.5 Spain Clinical Trial Packaging and Labelling Market, 2020-2030
  • 8.6 Rest of Europe Clinical Trial Packaging and Labelling Market, 2020-2030

9 Asia Pacific Clinical Trial Packaging and Labelling Market, 2020-2030

  • 9.1 China Clinical Trial Packaging and Labelling Market, 2020-2030
  • 9.2 Japan Clinical Trial Packaging and Labelling Market, 2020-2030
  • 9.3 India Clinical Trial Packaging and Labelling Market, 2020-2030
  • 9.4 Australia Clinical Trial Packaging and Labelling Market, 2020-2030
  • 9.5 ASEAN Clinical Trial Packaging and Labelling Market, 2020-2030
  • 9.6 Rest of Asia Pacific Clinical Trial Packaging and Labelling Market, 2020-2030

10 Latin America Clinical Trial Packaging and Labelling Market, 2020-2030

  • 10.1 Brazil Clinical Trial Packaging and Labelling Market, 2020-2030
  • 10.2 Mexico Clinical Trial Packaging and Labelling Market, 2020-2030
  • 10.3 Rest of Latin America Clinical Trial Packaging and Labelling Market, 2020-2030

11 MEA Clinical Trial Packaging and Labelling Market, 2020-2030

  • 11.1 GCC Clinical Trial Packaging and Labelling Market, 2020-2030
  • 11.2 South Africa Clinical Trial Packaging and Labelling Market, 2020-2030
  • 11.3 Rest of MEA Clinical Trial Packaging and Labelling Market, 2020-2030

12 Leading Companies in the Clinical Trial Packaging and Labelling Market, 2020-2030

  • 12.1 Fisher Clinical Services, Inc.
    • 12.1.1 Company Overview
    • 12.1.2 Product Portfolio
      • Clinical Label Services
    • 12.1.3 Recent Initiatives
  • 12.2 The Coghlan Group, Inc.
    • 12.2.1 Company Overview
    • 12.2.2 Product Portfolio
    • 12.2.3 Recent Initiatives
  • 12.3 Mawdsley-Brooks & Co. Ltd
    • 12.3.1 Company Overview
    • 12.3.2 Financial Overview
    • 12.3.3 Product Portfolio
    • 12.3.4 Recent Initiatives
  • 12.4 Piramal Enterprises Ltd
    • 12.4.1 Overview
    • 12.4.2 Financial Overview
    • 12.4.3 Product Portfolio
  • 12.5 Sharp
    • 12.5.1 Company Overview
    • 12.5.2 Product Portfolio
    • 12.5.3 Recent Initiatives
  • 12.6 Corden Pharma GmbH
    • 12.6.1 Company Overview
    • 12.6.2 Product Portfolio
    • 12.6.3 Recent Initiatives
  • 12.7 Bilcare Limited (now Liveo Research)
    • 12.7.1 Company Overview
    • 12.7.2 Financial Overview
    • 12.7.3 Product Portfolio
    • 12.7.4 Recent Initiatives
  • 12.8 Westrock Company
    • 12.8.1 Company Overview
    • 12.8.2 Financial Overview
    • 12.8.3 Product Portfolio
    • 12.8.4 Recent Initiatives
  • 12.9 Sentry Biopharma Services
    • 12.9.1 Company Overview
    • 12.9.2 Product Portfolio
  • 12.10 Korber Medipak Systems AG
    • 12.10.1 Company Overview
    • 12.10.2 Financial Overview
    • 12.10.3 Product Portfolio
    • 12.10.4 Recent Initiatives
  • 12.11 PCI Pharma Services
    • 12.11.1 Company Overview
    • 12.11.2 Financial Overview
    • 12.11.3 Product Portfolio
    • 12.11.4 Recent Initiatives
  • 12.12 Nextpharma Technologies Holding
    • 12.12.1 Company Overview
    • 12.12.2 Financial Overview
    • 12.12.3 Product Portfolio
    • 12.12.4 Recent Initiatives
  • 12.13 CSM
    • 12.13.1 Company Overview
    • 12.13.2 Financial Overview
    • 12.13.3 Product Portfolio

13 Conclusion of the Clinical Trial Packaging and Labelling Market, 2020-2030

14 Glossary

  • Associated Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain Report Evaluation Form

List of Tables

  • Table 4.1 Global Clinical Trial Packaging and Labelling Market Forecast by Type: Revenues (US$ million), AGR (%), 2019-2030
  • Table 4.2 Global Clinical Trial Packaging and Labelling Market Forecast by Type: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 4.3 Global Clinical Trial Packaging and Labelling Market Forecast for Primary Packaging: Revenue (US$ million), AGR (%), 2019-2030
  • Table 4.4 Global Clinical Trial Packaging and Labelling Market Forecast by for Primary Packaging: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 4.5 Global Clinical Trial Packaging and Labelling Market Forecast for Primary Packaging: Revenue (US$ million), AGR (%), 2019-2030
  • Table 4.6 Global Clinical Trial Packaging and Labelling Market Forecast by for Primary Packaging: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 5.1 Global Clinical Trial Packaging and Labelling Market Forecast by End Users: Revenue (US$ million), AGR (%), 2019-2030
  • Table 5.2 Global Clinical Trial Packaging and Labelling Market Forecast by End Users: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 6.1 Global Clinical Trial Packaging and Labelling Market Forecast by Country: Revenue (US$ million), AGR (%), 2019-2030
  • Table 6.2 Global Clinical Trial Packaging and Labelling Market Forecast by Country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 7.1 North America Clinical Trial Packaging and Labelling Market Forecast by Country: Revenue (US$ million), AGR (%), 2019-2030
  • Table 7.2 North America Clinical Trial Packaging and Labelling Market Forecast by Country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 7.3 North America Clinical Trial Packaging and Labelling Market Forecast by Type: Revenue (US$ million), AGR (%), 2019-2030
  • Table 7.4 North America Clinical Trial Packaging and Labelling Market Forecast by Type: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 7.5 North America Clinical Trial Packaging and Labelling Market Forecast by End User: Revenue (US$ million), AGR (%), 2019-2030
  • Table 7.6 North America Clinical Trial Packaging and Labelling Market Forecast by End User: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 7.6 U.S. Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 7.7 Canada Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 8.1 Europe Clinical Trial Packaging and Labelling Market Forecast by Country: Revenues (US$ million), 2019-2030
  • Table 8.2 Europe Clinical Trial Packaging and Labelling Market Forecast by Country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 8.3 Europe Clinical Trial Packaging and Labelling Market Forecast by Type: Revenue (US$ million), AGR (%), 2019-2030
  • Table 8.4 Europe Clinical Trial Packaging and Labelling Market Forecast by Type: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 8.5 Europe Clinical Trial Packaging and Labelling Market Forecast by End User: Revenue (US$ million), AGR (%), 2019-2030
  • Table 8.6 Europe Clinical Trial Packaging and Labelling Market Forecast by End User: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 8.7 Germany Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020- 2025, 2025-2030, 2020-2030
  • Table 8.8 France Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 8.9 UK Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 8.10 Italy Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 8.11 Spain Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 8.12 Rest of Europe Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 9.1 Asia Pacific Clinical Trial Packaging and Labelling Market Forecast by Country: Revenue (US$ million), AGR (%), 2019-2030
  • Table 9.2 Asia Pacific Clinical Trial Packaging and Labelling Market Forecast by Country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 9.3 Asia Pacific Clinical Trial Packaging and Labelling Market Forecast by Type: Revenue (US$ million), AGR (%), 2019-2030
  • Table 9.4 Asia Pacific Clinical Trial Packaging and Labelling Market Forecast by Type: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 9.5 Asia Pacific Clinical Trial Packaging and Labelling Market Forecast by End User: Revenue (US$ million), AGR (%), 2019-2030
  • Table 9.6 Asia Pacific Clinical Trial Packaging and Labelling Market Forecast by End User: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 9.7 China Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 9.8 Japan Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 9.9 India Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 9.10 Australia Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020- 2025, 2025-2030, 2020-2030
  • Table 9.11 ASEAN Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 9.11 Rest of APAC Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 10.1 Latin America Clinical Trial Packaging and Labelling Market Forecast by Country: Revenues (US$ million), AGR (%), 2019-2030
  • Table 10.2 Latin America Clinical Trial Packaging and Labelling Market Forecast by Country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 10.3 Latin America Clinical Trial Packaging and Labelling Market Forecast by Type: Revenues (US$ million), AGR (%), 2019-2030
  • Table 10.4 Latin America Clinical Trial Packaging and Labelling Market Forecast by Type: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 10.5 Latin America Clinical Trial Packaging and Labelling Market Forecast by End User: Revenue (US$ million), AGR (%), 2019-2030
  • Table 10.6 Latin America Clinical Trial Packaging and Labelling Market Forecast by End User: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 10.7 Brazil Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 10.8 Mexico Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 10.9 Rest of LATAM Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 11.1 MEA Clinical Trial Packaging and Labelling Market Forecast by Country: Revenue (US$ million), AGR (%), 2019-2030
  • Table 11.2 MEA Clinical Trial Packaging and Labelling Market Forecast by Country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 11.3 MEA Clinical Trial Packaging and Labelling Market Forecast by Type: Revenue (US$ million), AGR (%), 2019-2030
  • Table 11.4 MEA Clinical Trial Packaging and Labelling Market Forecast by Type: CAGR (%), 2020- 2025, 2025-2030, 2020-2030
  • Table 11.5 MEA Clinical Trial Packaging and Labelling Market Forecast by End User: Revenue (US$ million), AGR (%), 2019-2030
  • Table 11.6 MEA Clinical Trial Packaging and Labelling Market Forecast by End User: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 11.7 GCC Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 11.8 South Africa Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020- 2025, 2025-2030, 2020-2030
  • Table 11.9 Rest of MEA Clinical Trial Packaging and Labelling Market Forecast: CAGR (%), 2020- 2025, 2025-2030, 2020-2030
  • Table 12.1 Fisher Clinical Services, Inc.: Company Overview, 2019
  • Table 12.2: Product Portfolio
  • Table 12.3 Fisher Clinical Services, Inc.: Recent Initiatives
  • Table 12.4 Coghlan Group: Company Overview, 2019
  • Table 12.5: Coghlan Group: Product Portfolio
  • Table 12.6: Coghlan Group: Recent Initiatives
  • Table 12.7: Mawdsley-Brooks & Company Ltd.: Company Overview, 2019
  • Table 12.8: Mawdsley-Brooks & Company Ltd.: Revenue (US$ million), AGR (%), 2017-2019
  • Figure 12.1: Revenue (US$ million), AGR (%), 2017-2019
  • Table 12.9: Product Portfolio
  • Table 12.10: Recent Initiatives
  • Table 12.11 Company Overview, 2019
  • Figure 12.2: Revenue (US$ million), AGR (%), 2017-2019
  • Table 12.12: Sharp: Company Overview, 2019
  • Table 12.13: Sharp: Product Portfolio
  • Table 12.14: Sharp: Recent Initiatives
  • Table 12.15: Corden Pharma GmbH: Company Overview, 2019
  • Table 12.16: Corden Pharma GmbH: Recent Initiatives
  • Table 12.17: Bilcare Limited: Company Overview, 2019
  • Table 12.18: Bilcare Limited: Product Portfolio
  • Table 12.19: Bilcare Limited: Recent Initiatives
  • Table 12.20: Westrock Company: Company Overview, 2019
    • Westrock Company: Product Portfolio
  • Table 12.21: Westrock Company: Recent Initiatives
  • Table 12.22: Sentry Biopharma Services: Company Overview, 2019
  • Table 12.23: Sentry Biopharma Services Product Portfolio
  • Table 12.24: Korber Medipak Systems AG: Overview, 2019
  • Figure 12.5: Korber Medipak Systems AG: Revenue (US$ million), AGR (%), 2017-2019
  • Table 12.26: Korber Medipak Systems AG: Product Portfolio
  • Table 12.27: Korber Medipak Systems AG: Recent Initiatives
  • Table 12.28: PCI Pharma Services Overview, 2019
  • Table 12.29: PCI Pharma Services Overview, 2019: Revenue (US$ million), AGR (%), 2017-2019
  • Table 12.30: PCI Pharma Services Overview, 2019: Product Portfolio
  • Table 12.31: Recent Initiatives
  • Table 12.32: Nextpharma Technologies Holding: Overview, 2019
  • Table 12.33: Nextpharma Technologies Holding: Revenue (US$ million), AGR (%), 2017-2019
  • Table 12.34: Nextpharma Technologies Holding: Product Portfolio
  • Table 12.35: Nextpharma Technologies Holding: Recent Initiatives
  • Table 12.36: CSM: Overview, 2019
  • Table 12.37: CSM: Revenue (US$ million), AGR (%), 2017-2019
  • Table 12.38: CSM: Product Portfolio
  • Table 13.1 Global Clinical Trial Packaging and Labelling Market Forecast by Country: Revenue (US$ million), AGR (%), 2019-2030
  • Table 13.2 Global Clinical Trial Packaging and Labelling Market Forecast by Country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 13.3 Global Clinical Trial Packaging and Labelling Market Forecast by Type: Revenues (US$ million), AGR (%) 2019-2030
  • Table 13.4 Global Clinical Trial Packaging and Labelling Market Forecast by Type: CAGR (%), 2020-2025, 2025-2030, 2020-2030
  • Table 13.5 Global Clinical Trial Packaging and Labelling Market Forecast by End Users: Revenue (US$ million), AGR (%), 2019-2030
  • Table 13.6 Global Clinical Trial Packaging and Labelling Market Forecast by End Users: CAGR (%), 2020-2025, 2025-2030, 2020-2030

List of Figures

  • Figure 1.1 Global Clinical Trial Packaging and Labelling Market Segmentation
  • Figure 3.1 Number of clinical trials registered
  • Figure 3.2 R&D spend as a Percent of Total Sales (2019)
  • Figure 3.3 Biologics vs. Biosimilars Approvals by U.S. FDA
  • Figure 3.4 Porter's Five Forces Analysis
  • Figure 4.1 Global Clinical Trial Packaging and Labelling Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 4.2 Global Clinical Trial Packaging and Labelling Market for Primary Packaging, 2019-2030: Revenue ($ million), AGR (%)
  • Figure 4.3 Primary Packaging Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 4.4 Global Clinical Trial Packaging and Labelling Market for Secondary Packaging, 2019- 2030: Revenue (US$ million), AGR (%)
  • Figure 4.5 Secondary Packaging Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 5.1 Global Clinical Trial Packaging and Labelling Market Forecast by End Users: Market Share (%), 2020, 2025, 2030
  • Figure 5.2 Global Clinical Trial Packaging and Labelling Market for Drug Manufacturing Companies, 2019-2030: Revenue (US$ million), AGR (%)
  • Figure 5.3 Global Clinical Trial Packaging and Labelling Market for Research Labs, 2019-2030: Revenue (US$ million), AGR (%)
  • Figure 5.4 Global Clinical Trial Packaging and Labelling Market for CRO's, 2019-2030: Revenue (US$ million), AGR (%)
  • Figure 6.1 Global Clinical Trial Packaging and Labelling Market Forecast by Region: Market Share (%), 2020, 2025, 2030
  • Figure 7.1 North America Clinical Trial Packaging and Labelling Market Forecast by Country: Market Share (%), 2020, 2025, 2030
  • Figure 7.2 North America Clinical Trial Packaging and Labelling Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 7.3 North America Clinical Trial Packaging and Labelling Market for Primary Packaging, 2019-2030: Revenue (US$ million), AGR (%)
  • Figure 7.4 Primary Packaging Market Forecast by Type: Market Share (%), 2025
  • Figure 7.5 North America Clinical Trial Packaging and Labelling Market for Secondary Packaging, 2019-2030: Revenue (US$ million), AGR (%)
  • Figure 7.6 Secondary Packaging Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 7.7 North America Clinical Trial Packaging and Labelling Market Forecast by End User: Market Share (%), 2020, 2025, 2030
  • Figure 8.1 Europe Clinical Trial Packaging and Labelling Market Forecast by Country: Market Share (%), 2020, 2025, 2030
  • Figure 8.2 Europe Clinical Trial Packaging and Labelling Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 8.3 Europe Clinical Trial Packaging and Labelling Market for Primary Packaging, 2019- 2030: Revenue (US$ million), AGR (%)
  • Figure 8.4 Europe Primary Packaging Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 8.5 Europe Clinical Trial Packaging and Labelling Market for Secondary Packaging, 2019- 2030: Revenue (US$ million), AGR (%)
  • Figure 8.6 Europe Secondary Packaging Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 8.7 Europe Clinical Trial Packaging and Labelling Market Forecast by End User: Market Share (%), 2020, 2025, 2030
  • Figure 9.1 Asia Pacific Clinical Trial Packaging and Labelling Market Forecast by Country: Market Share (%), 2025
  • Figure 9.2 Asia Pacific Clinical Trial Packaging and Labelling Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 9.3 Asia Pacific Clinical Trial Packaging and Labelling Market for Primary Packaging, 2019- 2030: Revenue ($ million), AGR (%)
  • Figure 9.4 Asia Pacific Primary Packaging Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 9.5 Asia Pacific Clinical Trial Packaging and Labelling Market for Secondary Packaging, 2019-2030: Revenue (US$ million), AGR (%)
  • Figure 9.6 Asia Pacific Secondary Packaging Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 9.7 Asia Pacific Clinical Trial Packaging and Labelling Market Forecast by End User: Market Share (%), 2020, 2025, 2030
  • Figure 10.1 Latin America Clinical Trial Packaging and Labelling Market Forecast by Country: Market Share (%), 2020, 2025, 2030
  • Figure 10.2 Latin America Clinical Trial Packaging and Labelling Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 10.3 Latin America Clinical Trial Packaging and Labelling Market for Primary Packaging, 2019-2030: Revenue (US$ million), AGR (%)
  • Figure 10.4 Latin America Primary Packaging Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 10.5 Latin America Clinical Trial Packaging and Labelling Market for Secondary Packaging, 2019-2030: Revenue (US$ million), AGR (%)
  • Figure 10.6 Latin America Secondary Packaging Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 10.7 Latin America Clinical Trial Packaging and Labelling Market Forecast by End User: Market Share (%), 2020, 2025, 2030
  • Figure 11.1 MEA Clinical Trial Packaging and Labelling Market Forecast by Country: Market Share (%), 2020, 2025, 2030
  • Figure 11.2 MEA Clinical Trial Packaging and Labelling Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 11.3 MEA Clinical Trial Packaging and Labelling Market for Primary Packaging, 2019-2030: Revenue ($ million)
  • Figure 11.4 MEA Primary Packaging Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 11.5 MEA Clinical Trial Packaging and Labelling Market for Secondary Packaging, 2019- 2030: Revenue (US$ million), AGR (%)
  • Figure 11.6 MEA Secondary Packaging Market Forecast by Type: Market Share (%), 2020, 2025, 2030
  • Figure 11.7 MEA Clinical Trial Packaging and Labelling Market Forecast by End User: Market Share (%), 2020, 2025, 2030
  • Figure 13.1 Global Clinical Trial Packaging and Labelling Market Forecast by Region: Market Share (%), 2020, 2025, 2030